In March 2025, the company declared new strategies for a immediate-to-buyer giving of its Wegovy weight loss drug. The company established a new pharmacy, called NovoCare, which would charge shoppers $499 a month for entry to the drug, under fifty percent the price of the drug via other pharmaceutical distribution networks.[53]A weight loss plateau